Communiqués Avalo Therapeutics, Inc.

Actions

AVTX

US05338F3064

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 27/06/2024			Varia. 5j.	Varia. 1 janv.
13,2 ^USD	+1,23%		-0,45%	+45,05%

24/06	Avalo Therapeutics nomme un directeur juridique	MT
24/06	Avalo Therapeutics, Inc. nomme Paul Varki au poste de directeur juridique	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Avalo Therapeutics : 2024 Proxy Statement	27/06	PU
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer	24/06	AQ
Avalo Therapeutics : June 2024 Corporate Presentation	24/06	PU
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit	17/06	AQ
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates	13/05	AQ
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors	02/04	AQ
Avalo Reports 2023 Financial Results and Provides Business Updates	01/04	AQ
Avalo Reports 2023 Financial Results and Provides Business Updates	29/03	AQ
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million	27/03	AQ
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split	27/12	AQ
Avalo Therapeutics : 2023 Annual Meeting of Stockholders	19/12	PU
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split	07/12	AQ
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates	09/11	AQ
Avalo Completes Divestiture of AVTX-800 Series	31/10/23	AQ
Catheter Precision Inc. (NYSE American: VTAK) Nasdaq/NYSE Stocks Ignite Multiple Buzzers (AVTX, SPCB, INTZ)	11/10/23	AQ
Kaival Brands Innovation Group, Inc. (NASDAQ: KAVL) Global Expansion Generates Revenues w/Philip Morris (NYSE: PM): LIFW, AVTX, NVOS	29/09/23	AQ
BestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeutics	27/09/23	AQ
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation	26/09/23	AQ
Nano-Cap Medical Watchlist (TBRIF, CLRB, AVTX, SISI)	25/09/23	AQ
Avalo Enters into Agreement to Divest AVTX-800 Series	12/09/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Avalo Therapeutics, Inc.

Actions

AVTX

US05338F3064

Communiqués

Filtres